Cargando…
Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D
Main cause of severe illness and death in COVID-19 patients appears to be an excessive but ineffectual inflammatory immune response that may cause severe acute respiratory distress syndrome (ARDS). Vitamin D may favour an anti-inflammatory environment and improve cytotoxic response against some infe...
Autores principales: | Torres, Montserrat, Casado, Guiomar, Vigón, Lorena, Rodríguez-Mora, Sara, Mateos, Elena, Ramos-Martín, Fernando, López-Wolf, Daniel, Sanz-Moreno, José, Ryan-Murua, Pablo, Taboada-Martínez, María Luisa, López-Huertas, María Rosa, Cervero, Miguel, Coiras, Mayte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008199/ https://www.ncbi.nlm.nih.gov/pubmed/35468580 http://dx.doi.org/10.1016/j.biopha.2022.112965 |
Ejemplares similares
-
Beneficial Effect of Short-Term Supplementation of High Dose of Vitamin D(3) in Hospitalized Patients With COVID-19: A Multicenter, Single-Blinded, Prospective Randomized Pilot Clinical Trial
por: Cervero, Miguel, et al.
Publicado: (2022) -
Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkers
por: Galán, Miguel, et al.
Publicado: (2022) -
Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU
por: Vigón, Lorena, et al.
Publicado: (2021) -
Sustained Cytotoxic Response of Peripheral Blood Mononuclear Cells from Unvaccinated Individuals Admitted to the ICU Due to Critical COVID-19 Is Essential to Avoid a Fatal Outcome
por: Casado-Fernández, Guiomar, et al.
Publicado: (2023) -
Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity
por: Vigón, Lorena, et al.
Publicado: (2021)